CRISPR-modified cell lines for high-throughput SGLT1 and SGLT2 inhibitor screening
CRISPR-engineered glucagon-secreting cell lines with fluorescently tagged and knockout SGLT1/SGLT2 transporters for high-throughput screening of glucose uptake inhibitors. Enables compound specificity testing and time-co...